This grant, offered by the NCI, is designed for current NCI U01 research projects to propose revisions. Its primary purpose is to expand upon existing research questions or accelerate progress by integrating novel technical approaches or instruments. These technologies must have been developed with support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. The award aims to incentivize independent validation and hasten the adoption of these emerging technologies within appropriate research communities. Furthermore, as part of the NCI IMAT program, this funding opportunity seeks to foster interdisciplinary collaboration, promoting the development of innovative tools and methods that will significantly advance cancer research and scientific discovery.
Opportunity ID: 344764
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-23-007 |
| Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 02, 2022 |
| Last Updated Date: | Dec 02, 2022 |
| Original Closing Date for Applications: | Sep 01, 2023 |
| Current Closing Date for Applications: | Sep 01, 2023 |
| Archive Date: | Oct 07, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts County governments Public and State controlled institutions of higher education State governments City or township governments Special district governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities.As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278770 | Feb 01, 2023 | Sep 01, 2023 | View |
Package 1
Mandatory forms
344764 RR_SF424_5_0-5.0.pdf
344764 PHS398_CoverPageSupplement_5_0-5.0.pdf
344764 RR_OtherProjectInfo_1_4-1.4.pdf
344764 PerformanceSite_4_0-4.0.pdf
344764 RR_KeyPersonExpanded_4_0-4.0.pdf
344764 PHS398_ResearchPlan_5_0-5.0.pdf
344764 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344764 RR_Budget_3_0-3.0.pdf
344764 RR_SubawardBudget30_3_0-3.0.pdf
344764 PHS398_ModularBudget_1_2-1.2.pdf
344764 PHS_AssignmentRequestForm_3_0-3.0.pdf